Holocene Advisors, LP Neurocrine Biosciences Inc Transaction History

Holocene Advisors, LP

  • $22.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $24.3 Million - $26.5 Million
185,344 New
185,344 $25.5 Million
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $52.5 Million - $69.3 Million
692,611 New
692,611 $67.5 Million
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $14.7 Million - $17.8 Million
-175,620 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $12.7 Million - $16 Million
175,620 New
175,620 $14.8 Million

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email